Legacy Trust’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.51M Sell
5,175
-8
-0.2% -$2.63K 0.29% 72
2025
Q4
$1.82M Hold
5,183
0.34% 58
2025
Q3
$1.67M Sell
5,183
-24
-0.5% -$7.46K 0.33% 61
2025
Q2
$2.03M Buy
5,207
+10
+0.2% +$4.02K 0.5% 50
2025
Q1
$2.26M Buy
5,197
+15
+0.3% +$6.02K 0.54% 52
2024
Q4
$1.91M Sell
5,182
-49
-0.9% -$20.5K 0.44% 59
2024
Q3
$2.72M Buy
5,231
+17
+0.3% +$9.08K 0.62% 53
2024
Q2
$2.83M Hold
5,214
0.7% 48
2024
Q1
$2.7M Buy
5,214
+25
+0.5% +$12.4K 0.67% 49
2023
Q4
$2.45M Hold
5,189
0.64% 51
2023
Q3
$2.26M Buy
5,189
+6
+0.1% +$2.72K 0.66% 53
2023
Q2
$2.3M Buy
5,183
+7
+0.1% +$3.23K 0.63% 53
2023
Q1
$2.38M Hold
5,176
0.71% 49
2022
Q4
$2.66M Buy
+5,176
New +$2.63M 0.82% 41

Other funds holding ELV

Legacy Trust's ELV Position: Q1 2026 in Review

Legacy Trust reduced its Elevance Health (ELV) stake by 0.15% in Q1 2026, selling an estimated $2.63K and leaving 5,175 shares worth $1.51M. The position accounts for 0.29% of the portfolio, ranked #72.

Legacy Trust first reported a position in ELV in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.83M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Legacy Trust held 5,175 shares of Elevance Health worth $1.51M as of Q1 2026.
  • Legacy Trust sold 8 Elevance Health shares in Q1 2026, an estimated $2.63K.
  • Elevance Health made up 0.29% of Legacy Trust's portfolio in Q1 2026, its #72 holding.
  • Legacy Trust first reported a position in Elevance Health in Q4 2022 and has held it in 14 quarters since.
  • Legacy Trust's Elevance Health position peaked at $2.83M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Legacy Trust's 13F filing for Q1 2026, filed 14 Apr 2026.